The finding that the mast cell can play an important role in innate immunity to bacteria reopens the question of the true role of this controversial cell in the immune system.
Mast cells comprise a heterogeneous family of cell types derived from the bone marrow, which are mainly found resident in the connective tissues of the skin, lung and gut. Their common feature is prominent cytoplasmic granules containing heparin, histamine and proteases, which can be released -a process known as degranulation -into the tissues when the cells are appropriately activated. Traditionally, mast cells have been perceived as belonging to the effector arm of the immune system, and as coming into action at the end stage of an immune response or as part of the memory response. This is because of the apparent need for the mast cell to be 'armed', via specific surface receptors, with antigen-specific immunoglobulins (of classes E or G) from a previous immune response before it can react to parasite antigens.
Although the degranulation of mast cells at sites of metazoan parasite invasion is protective for the host, mast cell degranulation is more commonly associated in the clinical situation with adverse, sometimes fatal, reactions to harmless environmental allergens. This view of the mast cell has begun to change with the recent evidence that mast cells can also synthesize and release key immunoregulatory cytokines -interleukin-3 (IL-3), IL-4, IL-5, IL-6, IL-8 and tumor necrosis factor-␣ (TNF-␣) [1, 2] -and be phagocytic towards bacteria [3, 4] . These findings have given rise to the speculation that mast cells could be involved in regulation or fine tuning of the immune response, either as a negative-feedback mechanism or a form of T-cell independent help for B cells.
Two recent papers [5, 6] have pushed the redemption of the mast cell as a proactive force in the immune response a further step forward. Both groups of researchers used the mast cell deficient W/W v mouse strain, which lacks the receptor for stem cell factor (SCF), an important growth factor for mast cell progenitors and other blood cell types. Malaviya et al. [6] found that, compared with normal mice, the mast-cell deficient W/W v mouse strain was not able to clear efficiently either an intranasal or intraperitoneal infection with pathogenic Klebsiella pneumoniae. This defect was correlated with an impaired ability to produce TNF-␣ and recruit neutrophils to the site of infection. This in itself was not proof that the lack of mast cells was responsible for the decreased rate of bacterial clearance from the tissues, as these mice also have reduced numbers of other blood cell types. However, reconstitution of the W/W v mice with purified mast cells from normal mice brought the bacterial clearance rates back to normal levels and restored the production of early high levels of TNF-␣ and the recruitment of neutrophils into the infection site. Notably, the key bacterial component of the Klebsiella pneumoniae to which the mast cells responded was a minor subunit of type 1 fimbriae, a protein known as FimH.
The second paper, by Echtenacher et al. [5] , also involved the use of mast-cell deficient W/W v mice, this time in a model of acute septic peritonitis induced by surgical caecum ligation and puncture. When this procedure was performed in the mast-cell deficient W/W v mice, a striking 100 % mortality occurred, compared with the 25 % mortality in littermate control mice. Reconstitution of W/W v mice with bone-marrow-derived mast cells before surgery appeared to protect the W/W v mice from the lethal consequences of the caecum ligation and puncture procedure. Echtenacher et al. [5] suggested that the mast-cell effect was mediated by TNF-␣, because the injection of anti-TNF-␣ neutralizing antibodies suppressed the mast-cellmediated protection, while injection of a single dose of TNF-␣ protected unreconstituted W/W v mice from the caecum ligation and puncture procedure.
Taken together, these two papers [5, 6] demonstrate that mast cells play an important early role in the immune response against Gram-negative bacteria. The proposed scenario involves pathogenic bacteria invading tissues and directly activating mast cells to release stored TNF-␣ [7] . The released TNF-␣ induces the rapid recruitment of neutrophils to the site of infection, resulting in the early clearance of bacteria. Even though this is a compelling model, it remains to be clearly established whether there are functionally distinct mast-cell subtypes which can respond to bacterial components in this way, and which of these mast-cell subtypes are the primary source of TNF-␣.
Conventionally, mast cells have been divided into two types, mucosal-type mast cells and connective-tissue mast cells, based on differences in their granule proteases and the growth factors that drive their development. Mucosal mast cells express low levels of histamine and are regulated by T-cell derived IL-3 for their growth. Connective tissue mast cells are not T-cell dependent, but require SCF and other growth factors. Human mast cells can be divided into a tryptase-containing type (MC T ) found in the mucosa, and a tryptase-and chymotryptase-containing type (MC TC ) found in the connective tissue [8] . MC TC cells release histamine in response to immunological agentsantigen and immunoglobulin E -as well as to a wide variety of non-immunological agents, such as the bacterialderived formyl-methionine-containing peptides, substance P and the anaphylatoxin C5a. MC T cells appear to be Tcell dependent, with reduced numbers being found in immunodeficient patients, and are activated exclusively by immunoglobulin-E-dependent mechanisms [9] . Such differences could reflect the specialization of different mastcell subsets for bacterial or parasitic infections, that is to say for innate versus adaptive immune responses.
The important questions that still need to be answered include that of whether the mast-cell preparations used for the reconstitution experiments discussed above contained significant numbers of contaminating haemopoietic cell types, which could be a source of TNF-␣ during the infection. Furthermore, it needs to be determined whether the mast cells only recruit neutrophils to the site of infection, or whether other cells could be contributing to the clearance of the bacteria in these experiments. It is also important to determine what other bacterial/protozoan and metazoan components the mast cell can respond to in addition to type 1 fimbriae from Gram-negative bacteria.
In the light of these new findings, the role of the mast cell in host immune responses deserves to be reconsidered (Fig. 1) . The ability of mast cells to store and rapidly secrete TNF-␣ and recruit neutrophils to sites of infection, allied with their tissue distribution at all skin and mucosal sites, now places mast cells as an important and necessary first line of defence against bacterial infection. This role is in addition to the clear role of mast cells in acquired immunity to parasitic infections, and involvement in allergic reactions to environmental antigens. It is not clear whether the TNF-␣-producing mast cells involved in the innate anti-bacterial response are the same as those which mediate the allergic inflammatory reactions or produce immunoregulatory cytokines.
It will be important to determine which microbial components stimulate mast cells, and whether they stimulate the release of various subsets of mast-cell products. One possibility is that metazoan parasites do not have molecular components that can directly stimulate mast-cell mediator release, or have evolved means to avoid doing so. As a consequence, the immunoglobulin E arm of the adaptive immune system may have evolved as a mechanism to restore the host's ability to respond immediately to invading parasites. These questions represent an exciting and important challenge to immunologists and future work aimed at addressing them should lead to more detailed insight into how the immune system is organized and has evolved. 
